previous compound ID: 1998 next compound
InChIKey: RQZAXGRLVPAYTJ-GQFGMJRRSA-N
SMILES: CC1=C[C@@H]2[C@H](CC[C@]3([C@H]2CC[C@@]3(C(=O)C)OC(=O)C)C)[C@@]4(C1=CC(=O)CC4)C

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 53
"SD Macknight" "D Rotin" "J Goepp" "E Matthes" "B Kus" "DY Thomas" "GW Carlile" "JW Hanrahan" "R Robert" "J Liao"

chemical graph of compound 1998





CID is 11683
synonyms found at PubChem are:
MEGESTROL ACETATE, 595-33-5, Megace, Megace ES, Niagestin, Megestryl acetate, Megeron, Ovaban, Ovarid, Pallace, Magestin, Megestrol (Acetate), Ovaban (Veterinary), UNII-TJ2M0FR8ES, BDH 1298, NSC-71423, CCRIS 372, 17alpha-Hydroxy-6-methylpregna-4,6-diene-3,20-dione acetate, SC 10363, EINECS 209-864-5, 17alpha-Acetoxy-6-dehydro-6-methylprogesterone, 6-Dehydro-6-methyl-17alpha-acetoxyprogesterone, 6-Methyl-6-dehydro-17alpha-acetoxyprogesterone, TJ2M0FR8ES, Megestrol acetate [USAN], 17-Acetoxy-6-methylpregna-4,6-diene-3,20-dione, SC10363, Megestrol acetole [Progestins], MLS000028633, 6-Methyl-17alpha-hydroxy-delta(sup 6)-progesterone acetate, 17-Hydroxy-6-methylpregna-4,6-diene-3,20-dione 17-acetate, 17-alpha-Acetoxy-6-dehydro-6-methylprogesterone, 6-Dehydro-6-methyl-17-alpha-acetoxyprogesterone, 6-Methyl-6-dehydro-17-alpha-acetoxyprogesterone, Pregna-4,6-diene-3,20-dione, 17-(acetyloxy)-6-methyl-, 17-(acetyloxy)-6-methylpregna-4,6-diene-3,20-dione, 17alpha-Acetoxy-6-methylpregna-4,6-diene-3,20-dione, [(8R,9S,10R,13S,14S,17R)-17-acetyl-6,10,13-trimethyl-3-oxo-2,8,9,11,12,14,15,16-octahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate, 6-Methyl-17-alpha-acetoxypregna-4,6-diene-3,20-dione, 17-Hydroxy-6-methylpregna-4,6-diene-3,20-dione acetate, 6-Methyl-17-alpha-hydroxy-delta(sup 6)-progesterone acetate, 6-Methyl-delta(sup 6)-dehydro-17-alpha-acetoxyprogesterone, 6-Methyl-delta4,6-pregnadien-17alpha-ol-3,20-dione acetate, SC-10363, SMR000058691, Pregna-4,6-diene-3,20-dione, 17-hydroxy-6-methyl-, acetate, 6-Methyl-delta(sup 4,6)-pregnadien-17-alpha-ol-3,20-dione acetate, Megestrol acetate (USAN), DSSTox_CID_20683, DSSTox_RID_79539, DSSTox_GSID_40683, 6-Methyl-3,20-dioxopregna-4,6-dien-17-yl acetate, 51154-23-5, AK145584, Megestrol acetate [USAN:USP], Megestrol acetole, Megace;Megace ES, NCGC00016516-01, CAS-595-33-5, Megestrol-17-acetate, 6-Methyl-6-dehydro-17.alpha.-acetylprogesterone, 17.alpha.-Acetoxy-6-dehydro-6-methylprogesterone, 6-Dehydro-6-methyl-17.alpha.-acetoxyprogesterone, 6-Methyl-6-dehydro-17.alpha.-acetoxyprogesterone, Opera_ID_1511, Prestwick0_000956, Prestwick1_000956, Prestwick2_000956, Prestwick3_000956, SCHEMBL745, AC1L1XW9, BSPBio_000952, MLS000759501, MLS001074091, MLS001424055, par-100,2, SPBio_003101, BPBio1_001048, CHEMBL1201139, DTXSID9040683, CTK5B0088, MolPort-005-934-820, RQZAXGRLVPAYTJ-GQFGMJRRSA-N, BCPP000168, HMS1570P14, HMS2051I20, HMS2090N04, HMS2097P14, HMS2235D16, HMS3714P14, (8R,9S,10R,13S,14S,17R)-17-acetyl-6,10,13-trimethyl-3-oxo-2,3,8,9,10,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl acetate, BCP29265, BDH-1298, NSC71423, ZINC4097467, Tox21_110469, Tox21_302360, ANW-43468, LMST02030118, s1304, AKOS015894927, Tox21_110469_1, API0003279, BCP9000904, CCG-100899, CS-2065, DB00351, NC00149, 17-Acetoxy-6-methylpregna-4,20-dione, NCGC00024196-03, NCGC00024196-05, NCGC00255456-01, AC-24570, AJ-47998, AN-21566, AS-13384, BDH-1298, NSC-71423, HY-13676, I040, SC-16134, 17.alpha.-Acetoxy-6-methyl-4,20-dione, AB2000040, LS-118489, TR-031797, AB00490013, B1377, 17-Hydroxy-6-methylpregna-4,20-dione acetate, 17.alpha.-Acetoxy-6-methylpregna-4,20-dione, C08151, D00952, 14365-EP2311464A1, 14365-EP2316836A1, AB00383046-13, AB00383046-14, AB00383046-15, AB00383046_16, Pregna-4,20-dione, 17-(acetyloxy)-6-methyl-, 595M335, SR-01000000258, Pregna-4,20-dione, 17-hydroxy-6-methyl-, acetate, Q-201346, SR-01000000258-4, BRD-K19507340-001-03-1, Megestrol acetate, VETRANAL(TM), analytical standard, Megestrol acetate, analytical standard, for drug analysis, WLN: L E5 B666 OV KU MUTJ A1 E1 FV1 FOV1 L1, 6-Methyl-17.alpha.-hydroxy-.delta.(sup 6)-progesterone acetate, Megestrol acetate, European Pharmacopoeia (EP) Reference Standard, Megestrol acetate, United States Pharmacopeia (USP) Reference Standard, Megesgtrol Acetate, Pharmaceutical Secondary Standard; Certified Reference Material, Megestrol acetate for peak identification, European Pharmacopoeia (EP) Reference Standard, Megestrol acetate for system suitability, European Pharmacopoeia (EP) Reference Standard